| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |